<sup>18</sup>F-FDG-PET Imaging for Post-COVID-19 Brain and Skeletal Muscle Alterations

Scientific evidence concerning the subacute and long-term effects of coronavirus disease 2019 (COVID-19) is on the rise. It has been established that infection by serious acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a systemic process that involves multiple organs. The complications and...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Thorsten Rudroff, Craig D. Workman, Laura L. Boles Ponto
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	post-COVID PET glucose uptake brain muscle hypometabolism Microbiology QR1-502
Acceso en línea:	https://doaj.org/article/7d695c1ae51644629095d0119f406844
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:7d695c1ae51644629095d0119f406844
record_format	dspace
spelling	oai:doaj.org-article:7d695c1ae51644629095d0119f4068442021-11-25T19:14:08Z<sup>18</sup>F-FDG-PET Imaging for Post-COVID-19 Brain and Skeletal Muscle Alterations10.3390/v131122831999-4915https://doaj.org/article/7d695c1ae51644629095d0119f4068442021-11-01T00:00:00Zhttps://www.mdpi.com/1999-4915/13/11/2283https://doaj.org/toc/1999-4915Scientific evidence concerning the subacute and long-term effects of coronavirus disease 2019 (COVID-19) is on the rise. It has been established that infection by serious acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a systemic process that involves multiple organs. The complications and long-term consequences of COVID-19 are diverse and patients need a multidisciplinary treatment approach in the acute and post-acute stages of the disease. A significant proportion of COVID-19 patients experience neurological manifestations, some enduring for several months post-recovery. However, brain and skeletal muscle changes resultant from SARS CoV-2 infection remain largely unknown. Here, we provide a brief overview of the current knowledge, and usefulness, of [<sup>18</sup>F]fluorodeoxyglucose positron emission tomography/computed tomography (<sup>18</sup>F-FDG-PET/CT) to investigate brain and skeletal muscles changes in Post-COVID-19 patients with persistent symptoms. Furthermore, a brief discussion of future <sup>18</sup>F-FDG-PET/CT applications that might advance the current knowledge of the pathogenesis of post-COVID-19 is also provided.Thorsten RudroffCraig D. WorkmanLaura L. Boles PontoMDPI AGarticlepost-COVIDPETglucose uptakebrainmusclehypometabolismMicrobiologyQR1-502ENViruses, Vol 13, Iss 2283, p 2283 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	post-COVID PET glucose uptake brain muscle hypometabolism Microbiology QR1-502
spellingShingle	post-COVID PET glucose uptake brain muscle hypometabolism Microbiology QR1-502 Thorsten Rudroff Craig D. Workman Laura L. Boles Ponto <sup>18</sup>F-FDG-PET Imaging for Post-COVID-19 Brain and Skeletal Muscle Alterations
description	Scientific evidence concerning the subacute and long-term effects of coronavirus disease 2019 (COVID-19) is on the rise. It has been established that infection by serious acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a systemic process that involves multiple organs. The complications and long-term consequences of COVID-19 are diverse and patients need a multidisciplinary treatment approach in the acute and post-acute stages of the disease. A significant proportion of COVID-19 patients experience neurological manifestations, some enduring for several months post-recovery. However, brain and skeletal muscle changes resultant from SARS CoV-2 infection remain largely unknown. Here, we provide a brief overview of the current knowledge, and usefulness, of [<sup>18</sup>F]fluorodeoxyglucose positron emission tomography/computed tomography (<sup>18</sup>F-FDG-PET/CT) to investigate brain and skeletal muscles changes in Post-COVID-19 patients with persistent symptoms. Furthermore, a brief discussion of future <sup>18</sup>F-FDG-PET/CT applications that might advance the current knowledge of the pathogenesis of post-COVID-19 is also provided.
format	article
author	Thorsten Rudroff Craig D. Workman Laura L. Boles Ponto
author_facet	Thorsten Rudroff Craig D. Workman Laura L. Boles Ponto
author_sort	Thorsten Rudroff
title	<sup>18</sup>F-FDG-PET Imaging for Post-COVID-19 Brain and Skeletal Muscle Alterations
title_short	<sup>18</sup>F-FDG-PET Imaging for Post-COVID-19 Brain and Skeletal Muscle Alterations
title_full	<sup>18</sup>F-FDG-PET Imaging for Post-COVID-19 Brain and Skeletal Muscle Alterations
title_fullStr	<sup>18</sup>F-FDG-PET Imaging for Post-COVID-19 Brain and Skeletal Muscle Alterations
title_full_unstemmed	<sup>18</sup>F-FDG-PET Imaging for Post-COVID-19 Brain and Skeletal Muscle Alterations
title_sort	<sup>18</sup>f-fdg-pet imaging for post-covid-19 brain and skeletal muscle alterations
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/7d695c1ae51644629095d0119f406844
work_keys_str_mv	AT thorstenrudroff sup18supffdgpetimagingforpostcovid19brainandskeletalmusclealterations AT craigdworkman sup18supffdgpetimagingforpostcovid19brainandskeletalmusclealterations AT lauralbolesponto sup18supffdgpetimagingforpostcovid19brainandskeletalmusclealterations
_version_	1718410166296117248

<sup>18</sup>F-FDG-PET Imaging for Post-COVID-19 Brain and Skeletal Muscle Alterations

Ejemplares similares